Qigong Therapy for Individuals With Knee Osteoarthritis
Qigong Therapy for Osteoarthritis at Knees
1 other identifier
interventional
100
1 country
2
Brief Summary
The purpose of this study is to evaluate the effectiveness of Qigong therapy, an ancient Chinese practice, for pain relief and symptom improvement in people with knee osteoarthritis (OA). Study hypotheses: 1) Qigong therapy will result in greater reduction of pain and greater symptom improvement than sham treatment. 2) Individuals with a history of complementary and alternative medicine (CAM) use will be more likely to experience benefits of Qigong therapy than those without such experience.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_2
Started Jan 2005
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2005
CompletedFirst Submitted
Initial submission to the registry
February 23, 2005
CompletedFirst Posted
Study publicly available on registry
February 24, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2007
CompletedJanuary 25, 2008
January 1, 2008
2.6 years
February 23, 2005
January 23, 2008
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain, stiffness, and physical function scale results
Secondary Outcomes (5)
McGill Pain Questionnaire (MPQ-SF) results
Spielberger State-Trait Anxiety Scale (STAI) results
Daily dosage of drugs for pain relief
Range of motion for knees
Time to walk 50 feet
Interventions
Eligibility Criteria
You may qualify if:
- Diagnosis of osteoarthritis at least 6 months prior to study entry
- Able to understand English
You may not qualify if:
- Inflammatory joint disease affecting leg movement
- Knee replacement surgery on the OA knee
- Depo-corticosteroid knee injections within 3 months prior to study entry
- Pain in hips or lower back affecting leg movement
- New arthritis drugs or other painkillers within 2 weeks prior to study entry
- Investigational drugs within 30 days prior to study entry
- Asthma requiring oral corticosteroids within 4 weeks prior to study entry
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
University of Medicine and Dentistry, New Jersey-Robert Wood Johnson Medical School
Newark, New Jersey, 07103, United States
University of Medicine and Dentistry, New Jersey-Robert Wood Johnson Medical School
Piscataway, New Jersey, 08854, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kevin W. Chen, PhD MPH
Division of Addiction Psychiatry, University of Medicine and Dentistry, New Jersey-Robert Wood Johnson Medical School
- PRINCIPAL INVESTIGATOR
Leonard Sigal, MD
Rheumatology Department - Biomedical Sciences Program, University of Medicine and Dentistry, New Jersey-Robert Wood Johnson Medical School
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- NIH
Study Record Dates
First Submitted
February 23, 2005
First Posted
February 24, 2005
Study Start
January 1, 2005
Primary Completion
August 1, 2007
Study Completion
August 1, 2007
Last Updated
January 25, 2008
Record last verified: 2008-01